nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level
|
Verschoor, A. M. F. |
|
2016 |
159 |
2 |
p. 357-365 |
artikel |
2 |
Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes
|
Lim, Sue Zann |
|
2016 |
159 |
2 |
p. 229-244 |
artikel |
3 |
Clinical significance of noncalcified lung nodules in patients with breast cancer
|
Li, Feng |
|
2016 |
159 |
2 |
p. 265-271 |
artikel |
4 |
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer
|
Harano, K. |
|
2016 |
159 |
2 |
p. 367-374 |
artikel |
5 |
Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study
|
Singh, Deependra |
|
2016 |
159 |
2 |
p. 305-313 |
artikel |
6 |
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
|
Valachis, Antonis |
|
2016 |
159 |
2 |
p. 293-303 |
artikel |
7 |
Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial
|
Rogers, Laura Q. |
|
2016 |
159 |
2 |
p. 283-291 |
artikel |
8 |
Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
|
Ramshorst, Mette S. van |
|
2016 |
159 |
2 |
p. 393 |
artikel |
9 |
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
|
Rageth, Christoph J. |
|
2016 |
159 |
2 |
p. 203-213 |
artikel |
10 |
21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
|
Parsons, Benjamin M. |
|
2016 |
159 |
2 |
p. 315-326 |
artikel |
11 |
Impact of clinical trial on survival outcomes
|
Le Du, Fanny |
|
2016 |
159 |
2 |
p. 273-281 |
artikel |
12 |
Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity
|
Pinto, Pedro |
|
2016 |
159 |
2 |
p. 245-256 |
artikel |
13 |
Lifetime grain consumption and breast cancer risk
|
Farvid, Maryam S. |
|
2016 |
159 |
2 |
p. 335-345 |
artikel |
14 |
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
|
Bao, Ting |
|
2016 |
159 |
2 |
p. 327-333 |
artikel |
15 |
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
|
Aleskandarany, Mohammad A. |
|
2016 |
159 |
2 |
p. 215-227 |
artikel |
16 |
Reevaluation of RINT1 as a breast cancer predisposition gene
|
Li, Na |
|
2016 |
159 |
2 |
p. 385-392 |
artikel |
17 |
Resting heart rate as a prognostic factor for mortality in patients with breast cancer
|
Lee, Dong Hoon |
|
2016 |
159 |
2 |
p. 375-384 |
artikel |
18 |
St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
|
Focke, Cornelia M. |
|
2016 |
159 |
2 |
p. 257-263 |
artikel |
19 |
Vigorous physical activity and risk of breast cancer in the African American breast cancer epidemiology and risk consortium
|
Gong, Zhihong |
|
2016 |
159 |
2 |
p. 347-356 |
artikel |